{
    "NCTID": "NCT00987654",
    "trial_id": "EAXQpsJ9zkytvMrfZbP1",
    "phase": "Phase 1 & 2",
    "title": "Efficacy Study of Palovarotene in Fibrodysplasia Ossificans Progressiva",
    "brief_summary": "An investigation into the efficacy of Palovarotene in reducing heterotopic ossification in FOP patients.",
    "drug": "Palovarotene",
    "description": "This Phase II clinical trial explores the potential of palovarotene to limit the progression of bone formation in soft tissues among patients with Fibrodysplasia Ossificans Progressiva.",
    "disease_targeted": "Fibrodysplasia Ossificans Progressiva",
    "inclusion_criteria": [
      { "criterion": "Patients aged 12 to 60 years." },
      { "criterion": "Documented history of FOP with active flare-ups." }
    ],
    "exclusion_criteria": [
      { "criterion": "Pregnant or breastfeeding women." },
      { "criterion": "Concurrent use of high-dose corticosteroids." }
    ],
    "enrollment_capacity": 50,
    "sponsor": "Rare Bone Disease Institute",
    "locations": [
      {
        "location_id": "LOC2002",
        "address": "456 Clinical Way",
        "city": "San Francisco",
        "state": "CA",
        "country": "USA"
      },
      {
        "location_id": "LOC2003",
        "address": "789 Health Ave",
        "city": "Seattle",
        "state": "WA",
        "country": "USA"
      }
    ],
    "start_date": "2025-06-15T00:00:00Z",
    "end_date": "2027-06-15T00:00:00Z",
    "status": "active",
    "contact_info": {
      "phone": "+1-415-555-0202",
      "email": "contact@rarebonedisease.org",
      "website": "https://www.rarebonedisease.org"
    },
    "data_security_details": "Data is stored on secure, HIPAA-compliant servers with regular audits and end-to-end encryption.",
    "study_results": [
      {
        "date": "2026-01-01T00:00:00Z",
        "result_summary": "Interim analysis shows a reduction in new ossification events in treated patients.",
        "outcome": "positive"
      }
    ],
    "adverse_events": [
      {
        "date": "2025-07-20T00:00:00Z",
        "event_description": "Mild gastrointestinal discomfort observed in several participants.",
        "severity": "mild"
      }
    ],
    "created_at": "2025-03-02T13:00:00Z",
    "updated_at": "2025-07-21T10:00:00Z",
    "additional_comments": [
      "Dose adjustments may be necessary based on ongoing observations."
    ],
    "matching_criteria": [
      "age range 12-60",
      "active flare-up markers"
    ]
  }
  